INOVIO Receives $71 Million Contract From U.S. Department of Defense To Scale Up Manufacture of CELLECTRA® 3PSP Smart Device and Procurement of CELLECTRA® 2000 for COVID-19 DNA Vaccine
- Tuesday, June 23, 2020, 7:02
- Finance
- Add a comment
PLYMOUTH MEETING, Pa., June 23, 2020 /PRNewswire/ — INOVIO (NASDAQ:INO) today announced it has received $71 million funding from the U.S. Department of Defense (DoD) to support the large-scale manufacture of the company’s proprietary CELLECTRA® 3PSP smart device and the procurement of…
About the Author
adminasapcorp has written 41552 stories on this site.